Alzheimer's disease Trials in Oceanside, United States
Conditions / Alzheimer's disease / Oceanside, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00575055 | Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) | COMPLETED | PHASE3 |
| NCT02956486 | A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT01969136 | Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT00937352 | A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT02547818 | Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT00574132 | Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) | COMPLETED | PHASE3 |
| NCT03036280 | A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease_ | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00838110 | A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT02484547 | 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT02006641 | Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil | COMPLETED | PHASE3 |